Insider Trading History of Okey Stephanie

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Okey Stephanie since 2020. This trader's CIK number is 1742616. At the time of last reporting, Okey Stephanie was the Officer of Ptc Therapeutics, Inc.. (stock ticker symbol PTCT). Also see all insider trading activities at Ptc Therapeutics, Inc..

Note that in the past Okey Stephanie also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Crinetics Pharmaceuticals, Inc. (CRNX) by Okey Stephanie

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 CRNX 0 $0 17,500 $811,650 17,500 $320,075

Yearly summary of insider trading at Ptc Therapeutics, Inc. (PTCT) by Okey Stephanie

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 PTCT 0 $0 5,000 $270,000 0 $0
2022 PTCT 0 $0 2,296 $118,521 0 $0
2021 PTCT 0 $0 1,650 $66,094 0 $0
2020 PTCT 0 $0 687 $42,953 0 $0


Insider trading activities at 2 companies by Okey Stephanie:

1. Crinetics Pharmaceuticals, Inc. (CRNX)

2. Ptc Therapeutics, Inc. (PTCT)

Table 1. Insider trading of Crinetics Pharmaceuticals, Inc. (CRNX) by Okey Stephanie

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-03-28 CRNX Sale 17,500 46.38 811,650
2024-03-28 CRNX Option Ex 17,500 18.29 320,075

Table 2. Insider trading of Ptc Therapeutics, Inc. (PTCT) by Okey Stephanie

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-03-13 PTCT Sale 5,000 54.00 270,000
2022-08-09 PTCT Sale 2,296 51.62 118,521
2021-08-13 PTCT Sale 1,650 40.06 66,094
2020-12-08 PTCT Sale 687 62.52 42,953

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Okey Stephanie (Officer of Ptc Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.